ARCHIVES

Pazdur Waxes On Calumet City And Krebiozen; Parkinson Takes Interim CMO Job at Zyngenia

This article is from The Cancer Letter archive.

Vol. 38 No. 17 | April 27, 2012

Download PDF Visit The Full Archive

Related Articles

FDA, NCI Seek Compromise On Survival Endpoints

June 16, 1989

Oncology ManagementL Tax-Exempt Bonds Issued To Expand UPCI; Sentillion, Dua Partner on Info System

March 5, 1999

Tumors Harder To Detect In Women In Their Forties

August 27, 2010

Guidelines Proposed For Control Grants

January 25, 1980

Guest Editorial: Omics Checklist Done, Now Create Business Model For Tests

February 7, 2013

NCI Plans Preclinical Studies Of Endoxifen, A Tamoxifen Metabolite.

August 7, 2009